Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples